f-patent drugs -- as well are more common medicines and health products such as aspirins and vitamins.\n\nConvincing those families to sell has been seen as a tall order, which could present many companies with tough choices after Singh's decision to offload his family's 34.8 percent stake in Ranbaxy.\n\nThat is the advantage of being a leader and changing the rules of the game, Singh said. (Oth